Methods of Measuring Signaling Pathway Activity for Selection of Therapeutic Agents

Celcuity Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2018/022936, filed Mar 16, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 12,320,799	Methods of Measuring Signaling Pathway Activity for Selection of Therapeutic Agents Celcuity Inc. In force Ends no later than Jan 21, 2039 · Medium confidence	Celcuity Inc.	In force	Ends no later than Jan 21, 2039	Ends no later than Jan 21, 2039	Medium confidence
US 11,333,659	Methods of Measuring Signaling Pathway Activity for Selection of Therapeutic Agents Celcuity Inc. In force Term ends Dec 29, 2039 · High confidence	Celcuity Inc.	In force	Term ends Dec 29, 2039	Term ends Dec 29, 2039	High confidence

2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.